Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy
作者： Virginia Wong
DOI: 10.1080/1363849031000139306
关键词: Evidence-based practice 、 Physical therapy 、 Neurological disorder 、 Drooling 、 Clinical trial 、 Botulinum toxin type 、 Spasticity 、 Cerebral palsy 、 Medicine 、 Evidence-based medicine
摘要: A systematic review with the Sachett model of evidence-based medicine use Botulinum toxin type (BTX) for intervention in children Cerebral Palsy (CP) is highlighted. Currently, evidence showed that BTX useful treating pes equinus due to spasticity gastrocnemius-soleus muscles. However, careful patient selection and goals treatment have be addressed. More multi-centre clinical trials standardized protocols are needed before widespread recommendation CP can made.
core.ac.uk
hku.hk
sci-hub.se 参考文章(72)
L Andrew Koman, James F Mooney III, Beth Paterson Smith, Francis Walker, Judith M Leon, BOTOX Study Group, Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Lower Extremity Spasticity in Cerebral Palsy: A Randomized, Double-blind, Placebo-controlled Trial Journal of Pediatric Orthopaedics. ,vol. 20, pp. 108- 115 ,(2000) , 10.1097/01241398-200001000-00022
Mark E. Gormley, Deborah Gaebler-Spira, Mauricio R. Delgado, Use of Botulinum Toxin Type A in Pediatric Patients With Cerebral Palsy: A Three-Center Retrospective Chart Review: Journal of Child Neurology. ,vol. 16, pp. 113- 118 ,(2001) , 10.1177/088307380101600209
L. A. Koman, A. Brashear, S. Rosenfeld, H. Chambers, B. Russman, M. Rang, L. Root, E. Ferrari, J. Garcia de Yebenes Prous, B. P. Smith, C. Turkel, J. M. Walcott, P. T. Molloy, Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Equinus Foot Deformity in Cerebral Palsy: A Multicenter, Open-Label Clinical Trial Pediatrics. ,vol. 108, pp. 1062- 1071 ,(2001) , 10.1542/PEDS.108.5.1062
Raul Calderon-Gonzalez, Raul Calderon-Sepulveda, Moises Rincon-Reyes, Jorge Garcia-Ramirez, Eugenia Mino-Arango, Botulinum toxin a in management of cerebral palsy Pediatric Neurology. ,vol. 10, pp. 284- 288 ,(1994) , 10.1016/0887-8994(94)90123-6
Eun Sook Park, Chang Il Park, Deog Young Kim, Yong Rae Kim, The effect of spasticity on cortical somatosensory-evoked potentials: Changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection Archives of Physical Medicine and Rehabilitation. ,vol. 83, pp. 1592- 1596 ,(2002) , 10.1053/APMR.2002.34623
Dana L. Suskind, Ann Tilton, Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. ,vol. 112, pp. 73- 81 ,(2002) , 10.1097/00005537-200201000-00014
D. L. Damiano, J. Quinlivan, B. F. Owen, M. Shaffrey, M. F. Abel, Spasticity versus strength in cerebral palsy: relationships among involuntary resistance, voluntary torque, and motor function. European Journal of Neurology. ,vol. 8, pp. 40- 49 ,(2001) , 10.1046/J.1468-1331.2001.00037.X
H. G. Chambers, Treatment of functional limitations at the knee in ambulatory children with cerebral palsy. European Journal of Neurology. ,vol. 8, pp. 59- 74 ,(2001) , 10.1046/J.1468-1331.2001.00039.X
F. Heinen, J. Wissel, A. Philipsen, V. Mall, J. Leititis, A. Schenkel, R. Stücker, R. Korinthenberg, Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A. Neuropediatrics. ,vol. 28, pp. 307- 313 ,(1997) , 10.1055/S-2007-973721
I S. Corry, A P. Cosgroce, EG Walsh, D. McClean, HK Graham, Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Developmental Medicine & Child Neurology. ,vol. 39, pp. 185- 193 ,(2008) , 10.1111/J.1469-8749.1997.TB07408.X